China Advanced Constructn Mtrls Grp Inc (NASDAQ:CADC), a provider of ready-mix concrete and related technical services in China, on February 12, 2013, has announced its financial results for the second quarter ended December 31, 2013. Revenue decreased 45% year over year to $11.8 million. — Gross margin at 12.7%. — Net loss available to common shareholders of $5.7 million or loss per share of $3.83. $29.4 million in working capital at December 31, 2013. China Advanced Constructn Mtrls Grp Inc (NASDAQ:CADC) stock opened at $6.70 in last trading session, and closed at $5.77, trading in the range of $5.15 – $6.70. The stock showed a negative weekly performance of -13.75%.
DURECT Corporation (NASDAQ:DRRX) announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter for POSIDUR™ (SABER®-Bupivacaine), an investigational drug for administration into the surgical site to produce post-surgical analgesia. Based on its review, the FDA has determined that they cannot approve the NDA in its present form, stating the NDA does not contain sufficient information to demonstrate that POSIDUR is safe when used in the manner described in the proposed label, and the FDA has indicated that additional clinical safety studies need to be conducted. DURECT is evaluating the issues described in the Complete Response Letter and plans to have further discussions with the FDA around them. DURECT Corporation (NASDAQ:DRRX) shares closed at $1.55 on last trade day, by losing -20.51%. Stock 52 week range is $0.76 – $2.69. Company’s market capitalization is $171.11 billion.
Cereplast Inc (OTCMKTS:CERP) is engaged in developing and commercializing bio-based resins through two product families: Cereplast Compostables Resins, which are compostable, renewable, ecologically sound substitutes for petroleum-based plastics, and Cereplast Sustainables resins (including the Cereplast Hybrid Resins product line), which replaces up to 90% of the petroleum-based content of traditional plastics with materials from renewable resources. Cereplast Inc (OTCMKTS:CERP) stock decreased -17.39% and finished the last session at $0.0019. The EPS of the stock remained -0.59. Company’s market capitalization is $1.89 million.
Dehaier Medical Systems Ltd (NASDAQ:DHRM) designs, develops and markets its branded products in China. The Company imports the majority of the products and medical components it sells to its customers. The Company designs and develops some of the medical components that are part of the branded products to be distributed. Some of these medical components are manufactured by contractors in China because it does not have a manufacturing facility. Dehaier Medical Systems Ltd (NASDAQ:DHRM) stock opened at $10.53 in last trading session and closed at $9.14. The 52 week range of the stock is $1.81 – $12.39 and the day range was $8.89 – $10.57.